JPMorgan Chase & Co. raised its position in shares of Exponent Inc. (NASDAQ:EXPO) by 1.2% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 289,869 shares of the company’s stock after buying an additional 3,445 shares during the period. JPMorgan Chase & Co. owned 1.09% of Exponent worth $16,931,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also modified their holdings of the stock. PNC Financial Services Group Inc. boosted its position in shares of Exponent by 1,814.5% in the second quarter. PNC Financial Services Group Inc. now owns 258,417 shares of the company’s stock worth $15,094,000 after buying an additional 244,919 shares in the last quarter. Henderson Group PLC boosted its position in shares of Exponent by 57.6% in the second quarter. Henderson Group PLC now owns 350,913 shares of the company’s stock worth $20,497,000 after buying an additional 128,261 shares in the last quarter. Emerald Acquisition Ltd. acquired a new position in shares of Exponent during the second quarter worth about $4,774,000. Panagora Asset Management Inc. boosted its position in shares of Exponent by 66.6% in the first quarter. Panagora Asset Management Inc. now owns 133,631 shares of the company’s stock worth $6,816,000 after buying an additional 53,421 shares in the last quarter. Finally, GW&K Investment Management LLC boosted its position in shares of Exponent by 17.2% in the second quarter. GW&K Investment Management LLC now owns 316,076 shares of the company’s stock worth $18,462,000 after buying an additional 46,418 shares in the last quarter. Hedge funds and other institutional investors own 91.46% of the company’s stock.
Exponent Inc. (NASDAQ:EXPO) traded down 1.18% on Thursday, reaching $50.19. 23,279 shares of the company traded hands. The company has a market capitalization of $1.30 billion, a PE ratio of 28.68 and a beta of 0.81. The stock’s 50 day moving average price is $50.36 and its 200 day moving average price is $51.90. Exponent Inc. has a one year low of $44.11 and a one year high of $59.71.
Exponent (NASDAQ:EXPO) last issued its quarterly earnings results on Tuesday, July 19th. The company reported $0.38 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.43 by $0.05. The business earned $77.30 million during the quarter, compared to the consensus estimate of $80.46 million. Exponent had a return on equity of 16.02% and a net margin of 15.13%. On average, equities research analysts predict that Exponent Inc. will post $1.59 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Friday, September 23rd. Investors of record on Friday, September 2nd were paid a $0.18 dividend. The ex-dividend date of this dividend was Wednesday, August 31st. This represents a $0.72 annualized dividend and a dividend yield of 1.42%. Exponent’s payout ratio is 41.62%.
Several research firms recently weighed in on EXPO. Cantor Fitzgerald began coverage on shares of Exponent in a report on Friday, August 26th. They set a “buy” rating and a $57.00 price target on the stock. Zacks Investment Research upgraded shares of Exponent from a “strong sell” rating to a “hold” rating in a report on Tuesday, September 20th. Finally, Avondale Partners began coverage on shares of Exponent in a report on Thursday, July 7th. They set a “market perform” rating and a $60.00 price target on the stock.
In related news, insider Paul Boehm sold 5,000 shares of the stock in a transaction dated Monday, July 25th. The shares were sold at an average price of $51.42, for a total transaction of $257,100.00. Following the sale, the insider now directly owns 29,045 shares of the company’s stock, valued at approximately $1,493,493.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Paul R. Johnston sold 5,500 shares of the stock in a transaction dated Friday, July 1st. The shares were sold at an average price of $58.07, for a total transaction of $319,385.00. Following the sale, the chief executive officer now directly owns 70,036 shares in the company, valued at $4,066,990.52. The disclosure for this sale can be found here. 3.50% of the stock is currently owned by corporate insiders.
Exponent Company Profile
Exponent, Inc, along with its subsidiaries, is a science and engineering consulting company. The Company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, technology development, thermal sciences and vehicle analysis services.
Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.